T1	p 74 140	patients with chemotherapy-induced painful peripheral neuropathy :
T2	p 277 278	.
T3	p 468 511	8 National Cancer Institute ( NCI ) -funded
T4	p 547 626	enrolled 231 patients who were 25 years or older being treated at community and
T5	p 636 680	settings between April 2008 and March 2011 .
T6	p 711 722	July 2012 .
T7	p 759 792	and comorbid pain risk , patients
T8	p 934 939	grade
T9	p 981 987	to the
T10	p 1073 1090	10 , representing
T11	p 1099 1119	chemotherapy-induced
T12	p 1555 1573	neuropathic pain .
T13	p 1668 1683	representing no
T14	p 1689 1711	and 10 representing as
T15	p 1745 1756	Individuals
T16	p 1767 1780	duloxetine as
T17	p 1923 1928	those
T18	p 2108 2129	Fifty-nine percent of
T19	p 2283 2325	patients with painful chemotherapy-induced
T20	i 16 26	duloxetine
T21	i 88 108	chemotherapy-induced
T22	i 234 254	chemotherapy-induced
T23	i 316 326	duloxetine
T24	i 335 340	daily
T25	i 430 448	placebo-controlled
T26	i 737 753	chemotherapeutic
T27	i 827 877	duloxetine followed by placebo or placebo followed
T28	i 881 893	duloxetine .
T29	i 1133 1187	paclitaxel , other taxane , or oxaliplatin treatment .
T30	i 1244 1259	1 capsule daily
T31	i 1270 1272	30
T32	i 1279 1300	duloxetine or placebo
T33	i 1326 1334	capsules
T34	i 1345 1347	30
T35	i 1354 1381	duloxetine or placebo daily
T36	i 1386 1387	4
T37	i 1461 1471	duloxetine
T38	i 1501 1508	placebo
T39	i 1767 1777	duloxetine
T40	i 1942 1949	placebo
T41	i 2050 2060	duloxetine
T42	i 2065 2072	placebo
T43	i 2156 2166	duloxetine
T44	i 2204 2211	placebo
T45	i 2305 2325	chemotherapy-induced
T46	i 2361 2371	duloxetine
T47	i 2386 2393	placebo
T48	o 30 67	pain , function , and quality of life
T49	o 109 116	painful
T50	o 234 254	chemotherapy-induced
T51	o 346 369	average pain severity .
T52	o 772 776	pain
T53	o 940 970	1 or higher sensory neuropathy
T54	o 1011 1038	Criteria for Adverse Events
T55	o 1099 1124	chemotherapy-induced pain
T56	o 1523 1554	chemotherapy-induced peripheral
T57	o 1567 1587	pain . Pain severity
T58	o 1617 1660	Pain Inventory-Short Form average pain item
T59	o 1684 1688	pain
T60	o 1840 1855	average pain of
T61	o 2023 2041	average pain score
T62	o 2231 2238	pain of
T63	o 2243 2251	amount .
T64	o 2305 2353	chemotherapy-induced peripheral neuropathy , the
T65	o 2428 2437	reduction
T66	o 2441 2445	pain